LCTX
Lineage Cell·AMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LCTX Filings
Filing Date
Form Description
Form Type
2025-11-28
Form 8-K - Current report
Key Events
2025-11-28 · Key Events
Form 8-K - Current report
2025-11-24
Form 8-K - Current report
Key Events
2025-11-24 · Key Events
Form 8-K - Current report
2025-11-14
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-14 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-12
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-12 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-06
Lineage Cell Therapeutics, Inc. (LCTX) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-06 · Earnings Call
Lineage Cell Therapeutics, Inc. (LCTX) Q3 2025 Earnings Call Transcript
2025-11-06
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-06 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-06
Form 8-K - Current report
Key Events
2025-11-06 · Key Events
Form 8-K - Current report
2025-09-26
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-09-26 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-09-24
Form 144 - Report of proposed sale of securities
Ownership
2025-09-24 · Ownership
Form 144 - Report of proposed sale of securities
